Acorda Therapeutics Inc. (ACOR) President and CEO Ron Cohen sells 55,000 Shares

President and CEO of Acorda Therapeutics Inc. (ACOR, Financial) Ron Cohen sells 55,000 shares of ACOR on 08/05/2010 at an average price of $35.93 a share.

Acorda Therapeutics Inc. has a market cap of $1.37 billion; its shares were traded at around $35.33 with and P/S ratio of 25.02.

ACOR is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, Jim Simons of Renaissance Technologies LLC, Bruce Kovner of Caxton Associates.

CEO Recent Trades:

  • Sell: President and CEO Ron Cohen sold 38,000 shares of ACOR stock on 03/09/2010 at the average price of 33.44. Ron Cohen owns at least 169,884 shares after this. The price of the stock has increased by 5.65% since.



CFO Recent Trades:

  • Sell: CFO David Lawrence sold 12,000 shares of ACOR stock on 03/10/2010 at the average price of 34.16. David Lawrence owns at least 10,800 shares after this. The price of the stock has increased by 3.43% since.



Directors and Officers Recent Trades:

  • Sell: Director Sandra Phd Panem sold 8,397 shares of ACOR stock on 06/14/2010 at the average price of 34. Sandra Phd Panem owns at least 345,685 shares after this. The price of the stock has increased by 3.91% since.

  • Sell: Director Sandra Phd Panem sold 8,394 shares of ACOR stock on 03/12/2010 at the average price of 35.01. Sandra Phd Panem owns at least 352,452 shares after this. The price of the stock has increased by 0.91% since.

  • Sell: Director Sandra Phd Panem sold 60,000 shares of ACOR stock on 03/10/2010 at the average price of 34. Sandra Phd Panem owns at least 360,846 shares after this. The price of the stock has increased by 3.91% since.

  • Sell: Chief Scientifc Officer Andrew Blight sold 4,173 shares of ACOR stock on 03/02/2010 at the average price of 32.21. Andrew Blight owns at least 32,108 shares after this. The price of the stock has increased by 9.69% since.